Hydroxocobalamin and Mirabegron drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Hydroxocobalamin (hydroxocobalamin) and Mirabegron (mirabegron). Common drug interactions include insomnia among females and interstitial lung disease among males.

The phase IV clinical study analyzes what interactions people have when they take Hydroxocobalamin and Mirabegron. It is created by eHealthMe based on reports of 32 people who take the same drugs from the FDA, and is updated regularly.

What is Hydroxocobalamin?

Hydroxocobalamin has active ingredients of hydroxocobalamin. It is often used in pernicious anaemia. eHealthMe is studying from 4,273 Hydroxocobalamin users. Check the latest studies of Hydroxocobalamin.

What is Mirabegron?

Mirabegron has active ingredients of mirabegron. It is often used in urge incontinence. eHealthMe is studying from 5,414 Mirabegron users. Check the latest studies of Mirabegron.



On Aug, 02, 2026

32 people who take Hydroxocobalamin and Mirabegron together, and have interactions are studied.

Hydroxocobalamin and Mirabegron drug interactions.

What are the common drug interactions of Hydroxocobalamin and Mirabegron, by gender? *:

female:

  1. Insomnia (sleeplessness)
  2. Meniere's disease (a disorder of the inner ear that can affect hearing and balance to a varying degree)
  3. Hypertension (high blood pressure)
  4. Lip swelling
  5. Oral mucosal eruption (a sudden appearing of rash on mucous membrane of mouth)
  6. Oral pain
  7. Periorbital cellulitis (inflammation and infection of the eyelid and the skin surrounding the eye)
  8. Blindness
  9. Cystitis haemorrhagic (blood in the urine and painful voiding)
  10. Erythema (redness of the skin)

male:

  1. Interstitial lung disease
  2. Rash
  3. Hypotension (abnormally low blood pressure)
  4. Lymphoma (cancer that begins in immune system cells)
  5. Oral herpes (viral infection of mouth)
  6. Post procedural infection
  7. Renal impairment (severely reduced kidney function)
  8. Skin cancer
  9. Thyroid disorder (thyroid diseases)
  10. Weight decreased

What are the common drug interactions of Hydroxocobalamin and Mirabegron, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Cystitis haemorrhagic (blood in the urine and painful voiding)
  2. Gastritis (inflammation of stomach)
  3. Haematuria (presence of blood in urine)
  4. Hypokalaemia (low potassium)
  5. Hypomagnesaemia (electrolyte disturbance in which there is an abnormally low level of magnesium in the blood)
  6. Cystitis radiation
  7. Urinary retention (the inability to completely or partially empty the bladder)

40-49:

  1. Periorbital cellulitis (inflammation and infection of the eyelid and the skin surrounding the eye)
  2. Blindness
  3. Erythema (redness of the skin)
  4. Hemiplegic migraine (migraine attacks occurring in two or more people in the same family who experience weakness on one side of body)
  5. Hot flush (sudden feelings of heat)
  6. Hypertension (high blood pressure)
  7. Hypoaesthesia (reduced sense of touch or sensation)
  8. Palpitations (feelings or sensations that your heart is pounding or racing)
  9. Pollakiuria (abnormally frequent passage of relatively small quantities or urine)

50-59:

  1. Lip swelling
  2. Oral mucosal eruption (a sudden appearing of rash on mucous membrane of mouth)
  3. Oral pain
  4. Arthralgia (joint pain)
  5. Frequent bowel movements
  6. Haemorrhage (bleeding)
  7. Headache (pain in head)
  8. Hyperhidrosis (abnormally increased sweating)
  9. Lymphoma (cancer that begins in immune system cells)
  10. Meningitis aseptic (a condition that causes the membranes covering your brain and spinal cord to become inflamed)

60+:

  1. Insomnia (sleeplessness)
  2. Meniere's disease (a disorder of the inner ear that can affect hearing and balance to a varying degree)
  3. Hypertension (high blood pressure)
  4. Hypomagnesaemia (electrolyte disturbance in which there is an abnormally low level of magnesium in the blood)
  5. Hypotension (abnormally low blood pressure)
  6. Ill-defined disorder
  7. Joint dislocation (a joint position is changed from normal position)
  8. Kyphoscoliosis (abnormal curving of the spine)
  9. Lung disorder (lung disease)
  10. Neck pain

What are the existing conditions these people have? *

  1. Vitamin B12 Deficiency: 4 people, 12.50%
  2. Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 3 people, 9.38%
  3. High Blood Pressure: 3 people, 9.38%
  4. Primary Progressive Multiple Sclerosis (primary progressive inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 3 people, 9.38%
  5. Hypertonic Bladder (bladder-storage function that causes a sudden urge to urinate): 3 people, 9.38%
  6. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 3 people, 9.38%
  7. Inflammation: 2 people, 6.25%
  8. Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 2 people, 6.25%
  9. Dry Mouth: 2 people, 6.25%
  10. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Hydroxocobalamin and Mirabegron?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Hydroxocobalamin and Mirabegron:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Hydroxocobalamin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Mirabegron:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Hydroxocobalamin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Mirabegron and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on hydroxocobalamin and mirabegron (the active ingredients of Hydroxocobalamin and Mirabegron, respectively), and Hydroxocobalamin and Mirabegron (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: